Home
Volume 14 (2024)
- Featured
  
  Ozone therapy associated with the treatment of osteonecrosis of the jaws. Narrative review
  
  23 Aug, 2024 | Volume 14 (2024), Volume 14 (2024) |
- Featured
  
  $Interfascial block in the dorsal region in patients with refractory chronic pain after a rear-end car accident.$
  Interfascial block in the dorsal region in patients with refractory chronic pain after a rear-end car accident.
  
  23 Aug, 2024 | Volume 14 (2024), Volume 14 (2024) |
- Featured
  
  Treatment of gonarthrosis secondary to gonarthrosis with intra-articular ozone. Case presentation.
  
  23 Aug, 2024 | Volume 14 (2024), Volume 14 (2024) |
Volume 13 (2023)
- Featured
  
  STRONG TRIUMPH OF DRA. ADRIANA SCHWARTZ AND AEPROMO IN FAVOR OF OZONE THERAPY
  
  2 Jul, 2023 | Uncategorized, Uncategorized, Volume 13 (2023), Volume 13 (2023) |
- Featured
  
  Novel application of using ozone for urobiomic restorative therapy with Microbiome Restorative Therapy in antibiotic resistant E. faecium canine urinary tract infection and to regain autonomic nerves
  
  2 Jul, 2023 | Volume 13 (2023) |
- Featured
  
  Glutathione: the master antioxidant
  
  2 Jul, 2023 | Volume 13 (2023) |
Volume 12 (2022)
- Featured
  
  Pharmaceuticals, COVID, vaccines, and ozone therapy
  
  30 May, 2022 | Volume 12 (2022) |
- Featured
  
  Prospective observational study, efficacy and safety of platelet growth concentrates combined with mesenchymal stem cells induced with ozone in hip osteoarthritis
  
  30 May, 2022 | Volume 12 (2022) |
- Featured
  
  Ozonised Saline Solution in treating Post-EBV-Fatigue Syndrome. Case Report and review of the literature
  
  30 May, 2022 | Volume 12 (2022) |
Volume 11 (2021)
- Featured
  
  Does the United States Drug Agency (FDA) make scientific decisions?
  
  12 Mar, 2022 | Volume 11 (2021), Volume 11 (2021) |
- Featured
  
  Who decides what a pseudo-therapy is? Evidence vs hasty opinions on ozone
  
  15 Sep, 2021 | Volume 11 (2021), Volume 11 (2021) |
- Featured
  
  Editorial. VACCINES, RESEARCH CONTRACTS AND OZONE THERAPY
  
  4 Jun, 2021 | Volume 11 (2021) |
Volume 10 (2020)
- Featured
  
  The challenge that COVID-19 represents for ozone therapy as complementary medicine
  
  27 Jul, 2020 | Volume 10 (2020) |
- Featured
  
  COVID-19 Dermatological manifestations. Presentation of two cases
  
  27 Jul, 2020 | Volume 10 (2020) |
- Featured
  
  Practical aspects in ozone therapy: Study of the ozone concentration in the ozonized saline solution
  
  27 Jul, 2020 | Volume 10 (2020) |
Volume 9 (2019)
- Featured
  
  Resolution of Neuropathic Ocular Pain with peri-ocular injections of Medicinal Ozone and Procaine: Case Report with Bibliographic Review
  
  5 Jun, 2019 | Volume 9 (2019) |
- Featured
  
  Rebellious Coccigodinia: Efficacy of the association of Ozone and Radiofrequency in the control of the pain. Report of one case
  
  5 Jun, 2019 | Volume 9 (2019) |
- Featured
  
  Recurrent chronic mastitis: ozonoterapia as a coadyuvant to the conventional treatment. Presentation of clinical case
  
  5 Jun, 2019 | Volume 9 (2019) |
Volume 8 (2018)
- Featured
  
  VOLUMEN 8. NÚMERO 2. ABSTRACT BOOK. XI RUSSIAN SCIENTIFIC CONFERENCE IN OZONE-THERAPY VI INTERNATIONAL JOINT CONFERENCE RUSSIAN-IMEOF-AEPROMO
  
  18 Sep, 2018 | Volume 8 (2018) |
- Featured
  
  Editorial. Ozone therapy and pseudoscience
  
  24 May, 2018 | Volume 8 (2018) |
- Featured
  
  Treatment of Cervical Discal Hernia with Ozone under Fluroscopic Navigation
  
  24 May, 2018 | Volume 8 (2018) |
Volume 7 (2017)
Volume 6 (2016)
Volume 5 (2015)
Volume 4 (2014)
Volume 3 (2013)
Volume 2 (2012)
Volume 1 (2011)
Journal Browsing
English (English)
- Español (Spanish)

Tag: Oleozon

Does the United States Drug Agency (FDA) make scientific decisions?

Posted by AEPROMO | 12 Mar, 2022 | Volume 11 (2021), Volume 11 (2021) |

Letters to the Editor Author Quintero Marino, Roberto Abstract The author analyzes...

Read More

Who decides what a pseudo-therapy is? Evidence vs hasty opinions on ozone

Posted by AEPROMO | 15 Sep, 2021 | Volume 11 (2021), Volume 11 (2021) |

Letter to the Director Author Luis Prieto Valiente, Carlos Álvarez Leiva, Blas García Medina,...

Read More

Effectiveness of the OLEOZON® oral like medication inner conduct in the endodontic treatment. Playa 2014.

Posted by AEPROMO | 15 May, 2017 | Volume 7 (2017) |

Original Paper Authors Javier Álvarez Rodríguez, Bernardo Wolfsohn Manhard, Wolfsohn, Montevideo,...

Read More

Clinical experience in the treatment of Epidemic Hemorrhagic Conjunctivitis with OLEOZON collyrium

Posted by AEPROMO | 4 May, 2012 | Volume 2 (2012) |

Original Paper Authors Mirta Copello Noblet, Silvia Menéndez Cepero, Adriana Schwartz Tapia ...

Read More

Search

Nota Bene

This journal was published from 2011 to 2018 with the name of “Revista Española de Ozonoterapia” (Spanish Journal of Ozone Therapy).

As of 2019 its name is “Ozone Therapy Global Journal”.

Esta revista se publicó desde 2011 hasta 2018 con el nombre de “Revista Española de Ozonoterapia”.
A partir del 2019 su nombre es“Ozone Therapy Global Journal”.

Journal issued in Madrid by AEPROMO (Spanish Association of Medical Professionals in Ozone Therapy)

Revista editada en Madrid por AEPROMO (Asociación Española de Profesionales Médicos en Ozonoterapia)

ISSN: 2659-8647

Comité Editorial

Latest papers

Published issues

Letter to the Director

Abstracts Books

Indexed

Follow us

Instructions and publication standards

If you wish to submit your paper, please read our Publication Guidelines carefully

Instructions and publication standards

Ethical Principles

AEPROMO y Ozone Therapy Global Journal tiene entre sus primeras prioridades garantizar la ética y calidad de los artículos publicados.

Como compromiso con la comunidad científica, suscribimos el código de conducta y las buenas prácticas definidas por el Comité sobre la Ética de la Publicación (COPE) para editores de revistas científicas.

Este código se puede consultar en este enlace: Code of Conduct for Journal Editors

Más información